Bold Therapeutics, a clinical-stage biopharmaceutical company developing BOLD-100, is pleased to announce that it is…
eabramovichJanuary 8, 2021
A Burnaby biotech company is partnering with a global pharmaceutical giant on research into advancing…
eabramovichJanuary 7, 2021
Prostate cancer is the second most common malignancy diagnosed in men and the sixth highest…
eabramovichJanuary 7, 2021
iCo Therapeutics (“iCo” or the “Company”) (TSX-V: ICO) (OTCQB: ICOTF), iCo Therapeutics, Inc. (“iCo”) and…
eabramovichJanuary 6, 2021
For the fifth time, OOOM presents its annual ranking: “OOOM 100: The World’s Most Inspiring…
eabramovichJanuary 5, 2021
Dr. Joseph Connors, Clinical Professor Emeritus in the Department of Medicine at UBC, was appointed…
eabramovichJanuary 4, 2021
The holiday season is upon us, and as research begins to slow towards the end…
eabramovichDecember 21, 2020
